NERV
Price:
$3.74
Market Cap:
$26.16M
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, ...[Read more]
Industry
Biotechnology
IPO Date
2014-07-01
Stock Exchange
NASDAQ
Ticker
NERV
According to Minerva Neurosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.02. This represents a change of 209.01% compared to the average of -0.65 of the last 4 quarters.
The mean historical PE Ratio of Minerva Neurosciences, Inc. over the last ten years is 2.51. The current -2.02 PE Ratio has changed -8148.18% with respect to the historical average. Over the past ten years (40 quarters), NERV's PE Ratio was at its highest in in the December 2017 quarter at 361.31. The PE Ratio was at its lowest in in the September 2016 quarter at -14.58.
Average
2.51
Median
-2.59
Minimum
-11.93
Maximum
49.22
Discovering the peaks and valleys of Minerva Neurosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 404.29%
Maximum Annual PE Ratio = 49.22
Minimum Annual Increase = -1380.64%
Minimum Annual PE Ratio = -11.93
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 11.68 | -975.66% |
| 2023 | -1.33 | 404.29% |
| 2022 | -0.26 | -61.45% |
| 2021 | -0.69 | -101.39% |
| 2020 | 49.22 | -1380.64% |
| 2019 | -3.84 | -26.26% |
| 2018 | -5.21 | -28.42% |
| 2017 | -7.28 | -38.95% |
| 2016 | -11.93 | 127.25% |
| 2015 | -5.25 | 173.65% |
The current PE Ratio of Minerva Neurosciences, Inc. (NERV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.36
5-year avg
11.72
10-year avg
2.51
Minerva Neurosciences, Inc.’s PE Ratio is greater than Klotho Neurosciences, Inc. (-2.58), less than Sonnet BioTherapeutics Holdings, Inc. (-0.37), greater than NeuroSense Therapeutics Ltd. (-3.52), greater than Exicure, Inc. (-5.40), greater than NeurAxis, Inc. (-3.55), greater than CollPlant Biotechnologies Ltd. (-2.20), less than TAO Synergies Inc. (-0.37), less than Rallybio Corporation (-0.72), less than Cadrenal Therapeutics, Inc. Common Stock (-1.58), greater than Enlivex Therapeutics Ltd. (-2.20),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.58 | $25.82M | |
| -0.37 | $8.43M | |
| -3.52 | $29.60M | |
| -5.40 | $42.96M | |
| -3.55 | $28.86M | |
| -2.20 | $26.70M | |
| -0.37 | $23.26M | |
| -0.72 | $28.16M | |
| -1.58 | $23.04M | |
| -2.20 | $28.19M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Minerva Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Minerva Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Minerva Neurosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Minerva Neurosciences, Inc. (NERV)?
What is the highest PE Ratio for Minerva Neurosciences, Inc. (NERV)?
What is the 3-year average PE Ratio for Minerva Neurosciences, Inc. (NERV)?
What is the 5-year average PE Ratio for Minerva Neurosciences, Inc. (NERV)?
How does the current PE Ratio for Minerva Neurosciences, Inc. (NERV) compare to its historical average?